Smokescreen: a targeted genotyping array for addiction research

[1]  A. Malarcher,et al.  Quitting Smoking Among Adults - United States, 2000-2015. , 2017, MMWR. Morbidity and mortality weekly report.

[2]  C. Spencer,et al.  A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium , 2016, bioRxiv.

[3]  Laura J Bierut,et al.  A multiancestry study identifies novel genetic associations with CHRNA5 methylation in human brain and risk of nicotine dependence. , 2015, Human molecular genetics.

[4]  S. Steinberg,et al.  Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence , 2015, Translational Psychiatry.

[5]  P. Visscher,et al.  Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index , 2015, Nature Genetics.

[6]  K. Kendler,et al.  Developmental Changes in Genetic and Shared Environmental Contributions to Smoking Initiation and Subsequent Smoking Quantity in Adolescence and Young Adulthood , 2015, Twin Research and Human Genetics.

[7]  L. Hawk,et al.  Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking , 2015, PloS one.

[8]  A. Bergen,et al.  Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date , 2015, CNS Drugs.

[9]  A. Malhotra,et al.  Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic , 2015, Molecular Psychiatry.

[10]  L. C. Bidwell,et al.  Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. , 2015, Addiction.

[11]  L. Hawk,et al.  Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. , 2015, The Lancet. Respiratory medicine.

[12]  Megan E. Piper,et al.  Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. , 2014, Annals of the American Thoracic Society.

[13]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[14]  G. Abecasis,et al.  Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.

[15]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[16]  L. Bierut,et al.  CYP2B6 Non-Coding Variation Associated with Smoking Cessation Is Also Associated with Differences in Allelic Expression, Splicing, and Nicotine Metabolism Independent of Common Amino-Acid Changes , 2013, PloS one.

[17]  Bruce S. Weir,et al.  Imputation-Based Genomic Coverage Assessments of Current Human Genotyping Arrays , 2013, G3: Genes, Genomes, Genetics.

[18]  G. Omenn,et al.  Evolution of Translational Omics: Lessons Learned and the Path Forward , 2013 .

[19]  Orli G. Bahcall,et al.  iCOGS collection provides a collaborative model , 2013, Nature Genetics.

[20]  Orli G. Bahcall.  COGS project and design of the iCOGS array , 2013, Nature Genetics.

[21]  P. Kwok,et al.  Nicotinic acetylcholine receptor variation and response to smoking cessation therapies , 2013, Pharmacogenetics and genomics.

[22]  Y. Pawitan,et al.  A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease , 2013, Molecular Psychiatry.

[23]  W. Iacono,et al.  Three Mutually Informative Ways to Understand the Genetic Relationships Among Behavioral Disinhibition, Alcohol Use, Drug Use, Nicotine Use/Dependence, and Their Co-occurrence: Twin Biometry, GCTA, and Genome-Wide Scoring , 2013, Behavior genetics.

[24]  Michael J Thun,et al.  50-year trends in smoking-related mortality in the United States. , 2013, The New England journal of medicine.

[25]  Scott F. Saccone,et al.  CHRNB3 is more strongly associated with Fagerström test for cigarette dependence-based nicotine dependence than cigarettes per day: phenotype definition changes genome-wide association studies results. , 2012, Addiction.

[26]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[27]  P. Elliott,et al.  UK Biobank: Current status and what it means for epidemiology , 2012 .

[28]  A. Goate,et al.  Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6. , 2012, Human molecular genetics.

[29]  Christina N. Lessov-Schlaggar,et al.  The genetics of addiction—a translational perspective , 2012, Translational Psychiatry.

[30]  Megan E. Piper,et al.  Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. , 2012, The American journal of psychiatry.

[31]  D. Goldman,et al.  The genetic basis of addictive disorders. , 2012, The Psychiatric clinics of North America.

[32]  Gary K. Chen,et al.  Genome-wide meta-analyses of smoking behaviors in African Americans , 2012, Translational Psychiatry.

[33]  Christine M. Micheel,et al.  COMMITTEE ON THE REVIEW OF OMICS-BASED TESTS FOR PREDICTING PATIENT OUTCOMES IN CLINICAL TRIALS , 2012 .

[34]  Teresa A. Webster,et al.  Design and coverage of high throughput genotyping arrays optimized for individuals of East Asian, African American, and Latino race/ethnicity using imputation and a novel hybrid SNP selection algorithm. , 2011, Genomics.

[35]  L. Bierut,et al.  Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials , 2011, Neuropsychopharmacology.

[36]  M. Munafo,et al.  CHRNA3 rs1051730 genotype and short-term smoking cessation. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[37]  Simon Cawley,et al.  Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. , 2011, Genomics.

[38]  L. Bierut,et al.  The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European–Americans , 2011, Pharmacogenetics and genomics.

[39]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[40]  Patrick F Sullivan,et al.  The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry , 2010, Neuron.

[41]  John P. Rice,et al.  Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans , 2010, Genes, brain, and behavior.

[42]  S. Dube,et al.  Vital signs: Current cigarette smoking among adults aged >=18 years --- United States, 2009 , 2010 .

[43]  C. Gieger,et al.  Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior , 2010, Nature Genetics.

[44]  C. Jepson,et al.  Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended‐Duration Transdermal Nicotine Therapy , 2010, Clinical pharmacology and therapeutics.

[45]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[46]  G. Uhl,et al.  Personalized Smoking Cessation: Interactions between Nicotine Dose, Dependence and Quit-Success Genotype Score , 2010, Molecular medicine.

[47]  Joel Gelernter,et al.  Meta-Analysis of 15 Genome-Wide Linkage Scans of Smoking Behavior , 2010, Biological Psychiatry.

[48]  John P. Rice,et al.  Genetic linkage findings for DSM‐IV nicotine withdrawal in two populations , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[49]  Megan E. Piper,et al.  Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[50]  N. Benowitz,et al.  Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African‐American Light Smokers , 2009, Clinical pharmacology and therapeutics.

[51]  Elissa J. Chesler,et al.  Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm , 2009, PloS one.

[52]  C. Lerman,et al.  Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study , 2009, Pharmacology Biochemistry and Behavior.

[53]  L. Epstein,et al.  Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo‐controlled Trial of Bupropion , 2008, Clinical pharmacology and therapeutics.

[54]  Scott F. Saccone,et al.  Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence , 2008, Bioinform..

[55]  E. S. Froelicher,et al.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. , 2008, American journal of preventive medicine.

[56]  D. Conti,et al.  Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation , 2008, Human molecular genetics.

[57]  Caryn Lerman,et al.  Molecular genetics of successful smoking cessation: convergent genome-wide association study results. , 2008, Archives of general psychiatry.

[58]  H. Wit.  Faculty Opinions recommendation of Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. , 2008 .

[59]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[60]  P. Muglia,et al.  α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking , 2008, Molecular Psychiatry.

[61]  K. Kendler,et al.  Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. , 2007, Archives of general psychiatry.

[62]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[63]  Christina N. Lessov-Schlaggar,et al.  CYP2A6 genotype and the metabolism and disposition kinetics of nicotine , 2006, Clinical pharmacology and therapeutics.

[64]  C. Lerman,et al.  Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation , 2006, Clinical pharmacology and therapeutics.

[65]  J. Kaprio,et al.  Genetic Architecture of Smoking Behavior: A Study of Finnish Adult Twins , 2006, Twin Research and Human Genetics.

[66]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[67]  G. Swan,et al.  Pharmacogenetics of Nicotine Metabolism in Twins: Methods and Procedures , 2004, Twin Research.

[68]  N. Benowitz,et al.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity , 2004, Clinical pharmacology and therapeutics.

[69]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[70]  H. Feiler,et al.  Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[71]  R. Tyndale,et al.  Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[72]  M. Jarvik,et al.  Nicotine Blood Levels and Subjective Craving for Cigarettes , 2000, Pharmacology Biochemistry and Behavior.

[73]  Patricia Dolan Mullen,et al.  Treating tobacco use and dependence: clinical practice guideline , 2000 .

[74]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[75]  Y. Funae,et al.  Role of human cytochrome P4502A6 in C-oxidation of nicotine. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[76]  Y. Funae,et al.  Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. , 1996, The Journal of pharmacology and experimental therapeutics.

[77]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[78]  Goran Arbanas.  Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .

[79]  Megan E. Piper,et al.  Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). , 2014, Addiction.

[80]  B. Lushniak,et al.  The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .

[81]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[82]  P. Visscher,et al.  Genome-wide complex trait analysis (GCTA): methods, data analyses, and interpretations. , 2013, Methods in molecular biology.

[83]  K. Fagerström.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[84]  Madison,et al.  Quitting Smoking Among Adults — United States, 2001–2010 , 2012 .

[85]  C. Gieger,et al.  Sequence variants at CHRNB 3 – CHRNA 6 and CYP 2 A 6 affect smoking behavior , 2010 .

[86]  L. Tanoue.  Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[87]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[88]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[89]  M. Tsuang,et al.  The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[90]  P. Sullivan,et al.  The genetic epidemiology of smoking. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.